Algeria vs Latvia: Cause of death, by non-communicable diseases, ages 5-14
Algeria
41.6%
in 2021
Latvia
42.3%
in 2021
Algeria rank
76th
Latvia rank
74th
Cause of death, by non-communicable diseases, ages 5-14 over time
- Algeria
- Latvia
How they compare
Latvia currently reports 42.3% against 41.6% in Algeria, a difference of 0.7%.
The two have swapped places 3 times across 6 shared years of data; in 2000 it was Algeria ahead.
Algeria ranks 76th and Latvia ranks 74th of 185 countries.
Across the 3 decades both report, Algeria averaged higher in 2 and Latvia in 1.
Head to head by decade
| Decade | Algeria | Latvia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 39.8% | 38.6% | 1.1% | Algeria |
| 2010s | 44.4% | 48.8% | 4.4% | Latvia |
| 2020s | 43.9% | 43.2% | 0.6% | Algeria |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 5-14, Algeria or Latvia?
- Latvia, at 42.3% against 41.6% in Algeria as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 5-14 between Algeria and Latvia?
- 0.7%, with Latvia ahead.
- How many years of comparable data are there for Algeria and Latvia?
- 6 years are reported by both, from 2000 to 2021.
- How do Algeria and Latvia rank globally for cause of death, by non-communicable diseases, ages 5-14?
- Algeria ranks 76th and Latvia ranks 74th of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 5-14 (% of total deaths ages 5-14). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of deaths ages 5-14 due to non-communicable diseases divided by number of all deaths ages 5-14, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.